Tirzepatide is a dual-agonist , meaning it works by targeting two hormones: GLP-1: helps regulate appetite, blood sugar, and digestion GIP: supports insulin response and reduces nausea Retatrutide is a triple-agonist , meaning it targets three hormones: GLP-1: helps regulate appetite, blood sugar, and digestion GIP: supports insulin response and reduces nausea Glucagon: affects energy use and fat metabolism Early studies show that retatrutide may be more successful than tirzepatide at managing diabetic kidney disease, as well as for weight control, while tirzepatide may be better at managing blood glucose
All statistical data in this article was reviewed for clinical accuracy in July 2026
[26] Current research attempts to bind structures to this active site to alter its functionality in order to prevent further viral RNA replication
Is Wegovy 7.2 mg as effective as Mounjaro 15 mg
Yes, clinical trials have shown that semaglutide can result in substantial weight loss when taken as directed along with a low-calorie diet and more physical activity
Under this structure, safety oversight rests with clinician judgment and pharmacy compliance, while the platform remains primarily administrative
